Atlas Trials

An Open Label, Dose-escalation Study, Assessing the Safety and Tolerability of a Collagen Peptide

Clinical trial NCT06232460 · COMPLETED

Trial details

NCT number
NCT06232460
Sponsor
Rousselot BVBA
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Tolerance
Start date
2024-02-08
Primary completion
2024-07-29
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.